Guidance

Subcategories:Clinical Criteria/Guidelines Ethics Legal Updates Legislation & Advocacy Meeting Reports Research Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

Ethical Concerns Influence What Constitutes Clear and Full Disclosure for Physicians

Bernard Rubin, DO, MPH | December 1, 2012

Money received from industry by physicians who can influence medical practice by their research, opinions, or roles in decision-making bodies should be clearly and fully disclosed

Ethics in Patients’ End-of-Life Care Compound Therapeutic Challenges for Rheumatologists

C. Ronald MacKenzie, MD | December 1, 2012

While end-of-life decisions are not frequently encountered in day-to-day practice, rheumatologists should be familiar with the ethical challenges that may arise when caring for patients in the ICU

Introducing RhMSUS—Musculoskeletal Ultrasound Certification in Rheumatology

Staff | November 15, 2012

The American College of Rheumatology (ACR) has launched the long-awaited certification program for musculoskeletal (MSUS) ultrasound in rheumatology

Therapies Aimed at Immune Cell Progenitors May Be Key to Reducing Post Myocardial Infarction Risk

Lara C. Pullen, PhD | November 9, 2012

Researchers have identified hematopoietic stem and progenitor cells that are liberated from bone marrow niches by a myocardial infarction.

Gadolinium Compounds Provide Insights into Pathogenesis of Fibrosing Diseases

Lara C. Pullen, PhD | November 9, 2012

Toll-like receptors appear to play an important role in the pathogenesis of fibrotic disorders including nephrogenic systemic fibrosis and systemic sclerosis.

ACR Report Outlines Reasonable Use of Ultrasound in Rheumatology

Kathy Holliman | November 1, 2012

The American College of Rheumatology’s (ACR) “Report on Reasonable Use of Musculoskeletal Ultrasonography in Rheumatology Clinical Practice” addresses using the technology in the context of an overall clinical evaluation

President’s Perspective: Big Questions, Bent Forks, and New Names

James O'Dell, MD | November 1, 2012

The ACR year in review

The ACR/ARHP Annual Meeting Provides Look Back at History of Rheumatology

Simon M. Helfgott, MD | November 1, 2012

The annual meeting of the American College of Rheumatology and Association of Rheumatology Health Professionals’ (ACR/ARHP) provide an opportunity to rewind through the history of rheumatology, and spotlight the speciality’s future

The ACR Research and Education Foundation Strengthens Its Mission With New Name, Tagline

Kimberly Retzlaff | November 1, 2012

The American College of Rheumatology’s Research and Education Foundation (REF) has renamed itself “The Rheumatology Research Foundation: Advancing treatment, Finding cures,” as part of an overall branding strategy for the ever-growing fundraising branch of the ACR that better defines its mission and goals

What Does Stage 2 Meaningful Use Mean for Your Rheumatology Practice?

Staff | November 1, 2012

The Centers for Medicare and Medicaid Services (CMS) Stage 2 Meaningful Use rule will focus on using data collected for more advanced clinical processes